These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36980654)

  • 1. Tumor Models and Drug Targeting In Vitro-Where Are We Today? Where Do We Go from Here?
    Krüger M; Kopp S
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
    Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
    Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Characters of Graphene Oxide Nanoparticles and Doxorubicin Against HCT-116 Colorectal Cancer Cells In Vitro.
    Banoon SR; Ghasemian A
    J Gastrointest Cancer; 2022 Jun; 53(2):410-414. PubMed ID: 33742370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
    Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphiphilic prodrug-decorated graphene oxide as a multi-functional drug delivery system for efficient cancer therapy.
    Huang C; Wu J; Jiang W; Liu R; Li Z; Luan Y
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():15-24. PubMed ID: 29752084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contraceptive prevalence, reproductive health and our common future.
    Diczfalusy E
    Contraception; 1991 Mar; 43(3):201-27. PubMed ID: 2036793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoformulations of doxorubicin: how far have we come and where do we go from here?
    Borišev I; Mrđanovic J; Petrovic D; Seke M; Jović D; Srđenović B; Latinovic N; Djordjevic A
    Nanotechnology; 2018 Aug; 29(33):332002. PubMed ID: 29798934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-Functional Tumor Theranostic Nanoplatform for MRI Guided Photothermal-Chemotherapy.
    Shi J; Wang B; Chen Z; Liu W; Pan J; Hou L; Zhang Z
    Pharm Res; 2016 Jun; 33(6):1472-85. PubMed ID: 26984128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo.
    Shi S; Yang K; Hong H; Chen F; Valdovinos HF; Goel S; Barnhart TE; Liu Z; Cai W
    Biomaterials; 2015 Jan; 39():39-46. PubMed ID: 25477170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.
    Vinothini K; Rajendran NK; Ramu A; Elumalai N; Rajan M
    Biomed Pharmacother; 2019 Feb; 110():906-917. PubMed ID: 30572195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Graphene Oxide Networks: Cytotoxicity and Synergy with Anticancer Agents.
    Bidram E; Sulistio A; Cho HJ; Amini A; Harris T; Zarrabi A; Qiao G; Stewart A; Dunstan DE
    ACS Appl Mater Interfaces; 2018 Dec; 10(50):43523-43532. PubMed ID: 30495922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
    García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
    BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Remote NIR-Controlled Drug Delivery Into Tumor Cells by Nanoplatform Modified with Tumoral-Acid-Cleavable Polyethylene Glycol.
    Shi J; Chen C; Pan J; Wang B; Zhao L; Hou L; Zhang Z
    J Biomed Nanotechnol; 2017 Dec; 13(9):1019-1034. PubMed ID: 31251136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect.
    Han C; Zhang C; Ma T; Zhang C; Luo J; Xu X; Zhao H; Chen Y; Kong L
    Acta Biomater; 2018 Sep; 77():268-281. PubMed ID: 30006311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WE-C-217BCD-06: In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene.
    Zhang Y; Yang K; Hong H; Engle J; Feng L; Theuer C; Barnhart T; Liu Z; Cai W
    Med Phys; 2012 Jun; 39(6Part27):3950. PubMed ID: 28520017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid-functionalized graphene oxide nanosheets via plasma etching as a platform to combine NIR anticancer phototherapy and targeted drug delivery.
    Mauro N; Scialabba C; Agnello S; Cavallaro G; Giammona G
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110201. PubMed ID: 31761243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations.
    Liu G; Shen H; Mao J; Zhang L; Jiang Z; Sun T; Lan Q; Zhang Z
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):6909-14. PubMed ID: 23883622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the science in cervical cancer: where we are today and where we need to go.
    Dizon DS; Mackay HJ; Thomas GM; Werner TL; Kohn EC; Hess D; Rose PG; Covens AL
    Cancer; 2014 Aug; 120(15):2282-8. PubMed ID: 24737608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.